Kaarka Tijaabada Antigen-ka ee degdega ah ee SARS-CoV-2

Rapid 2019-nCoV IqG/IqM Combo Tost Cnrd ts nn •mmunoenromatOQraphy ku salaysan hal tallaabo in vitro tost It « d<>siQfi©d for tho fuptd Qualitative delmmlnMion of IflG nr>d IflM antitxxJios ilaa 2020 SARS Cover -2) aadanaha som mmA. oc oo dhan bted Rapid 2019-nCoV IgG/IgM Combo Tost Cnrd waa ogaanshaha supplomont ee COVID-19 BKpoctod infekshanka patents bosidot nudoic nod tost kaas oo kicin kara saxnaanta tho cieloction (ama COVID19).

KOOBAN

Tho ”W coronnvirusos tx>Lonq to tbo P genus COVID-19 H nn nnnnnnnnnnnnnnnnnnnnnnnnnnn) n^ywplomatic mfoefod poog cah Sidoo kale noqo il mfoebous ah ©p hadda

MABADA

Rnpxl 2019-nCoV Combo Test Card waxa uu isticmaalaa pnnoplo ee immuno^nromotoflrap^y. Mqum ant>-bini'aadamka igM iyo mouse miti human igG Aniitxxlies nro immoeniizod on tho ntfroceHutose mentxane siday u kala horreeyaan, iyagoo ah laba tine oo shakhsi ah (igM line aM IgG bno) ee daaqada tijaabada ee qalabka tijaabada IgG itnc oo ah muunada ugu yar ee dhexmarta magaalada Xuubabka ku dhex jira aaladda tijaabada IM midabka recomt 2019-nCoV>nant 90M conjugate waxay sameeyaan comptexes gaar ah

nntibodios (IgM an

Maqnaanshaha tg cokxed band ee daaqada imtixaanku waxay tusinaysaa natiijada tijaabada ne^at/vo A bwn-

AALADAHA LA BIXIYAY

1 Raprt 2019-nCoV IgG-lgM Combo Test Card

2 Tusaalaha kaydinta

2 pL tubet capillary 4 Tilmaamaha Isticmaalka

AALADAHA LOO BAAHAN YAHAY LAAKIIN AAN LA BIXIN

Saacad ama saacad, lancets badbaado, u diyaargarowga khamriga

KAYDINTA

Ku kaydi qalabka lagu shubo 4 ilaa 30°C sanduuqa solod ee onflinnl Ha Froozo.
Taariikhda dhicitaanku if>dicaie
Waa in aan qalabku ku sii jirayn fts kiishashka asliga ah ee xidhan ilaa inta uu diyaar u yahay isticmaalka. Furitaanka ka dib, qalabka tijaabada waa in isla markiiba la isticmaalo. Dib ha u isticmaalin qalabka

KA TAXADARITAAN

1 Xirfadlayaasha in vitro diagnostic anaga oo keliya

2 Alaabta •$ stncUy ee loogu talagalay xirfadlayaasha caafimaadka u$e kaliya ee loo isticmaalo isticmaalka gaarka ah

3 Ha isticmaalin badeecada ka baxsan taariikhda exprsbon

4 Ha samayn badeecada haddii boorsada ，$ darnaged ama tM $«ai ay tahay txoken

5 Samee dhammaan shaybaarada sida kuwa suurtogalka ah in la is qaadsiiyo

6 Raac habka caadiga ah ee Lat> nidaamka aM tMOsafety fluxMhnet ee iyo asturidda poemiaii/infekshannada

Walxaha Marka habka tijaabada ah la dhammeeyo, tuur&e shaybaarada ka dib markii autoclaving at 121P kx ugu yaraan 20 min Daawaynta 0 5% Sodium HypochJonte f

Uruurinta Tuducyada ANO DIYAARINTA

1 Serum, balasmaha ama muunada dhiiga oo dhan waa inay ahaadaan coliedod uruSer xaaladaha iatxxatory caadiga ah.

2 Heat inacbvatKX) ee muunado, wtuch waxay keeni kartaa hemolyse iyo proton denaturation, waa in laga fogaado.

3 Tijaabadu waxay si fiican ugu shaqaysaa shaybaarada dhiiga oo dhan/serum i plasma oo cusub Haddii baadhista aan isla markiiba la samayn karin, serum I plasma waxa lagu kaydin karaa 2-8°C ilaa 3 maalmood haddii ay dhacdo Serum / Plasma speamens waxa lagu barafaysan karaa 20*C lor 3 bilood ama 70°C tef penod ka dheer Ka fogow baraf/thavwng soo noqnoqda wareegyada.

4 Sodium az>de waxaa lagu dari karaa ilaa 0.1% iyada oo aan saameyn ku yeelan natiijooyinka baaritaanka